| Value | ₹1,069 Cr |
|---|---|
| Execution period | Before end of July 2026 |
NSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.
Natco Pharma Ltd: key numbers
- Share price
- ₹782.40
- Market cap
- ₹15,348 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.4×Sector 45.9×
- Promoter holding
- 49.39%-0.03% QoQ
- FII holding
- 15.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natco Pharma Ltd
All →Natco Pharma Capital Structure Change
Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.
- Value
- ₹44.00 Cr
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 13 November 2026 to consider unaudited quarterly results and an interim dividend. Trading window closed until 15 November 2026.
Natco Pharma Capital Structure Change
Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.
- Value
- ₹1,279 Cr
Natco Pharma Product Launch
Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
Other board meeting outcome announcements
All →Pasari Spinning Mills Board Meeting Outcome
Pasari Spinning Mills reconstituted its Audit, NRC and SRC committees after an independent director resigned and Ms. Bhavna Agrawal was appointed. The change takes effect from the 30 October 2026 board meeting.
Teja Engineering Industries Board Meeting Outcome
Teja Engineering Industries informed NSE that its board appointed K. J. Tapiawala & Associates as internal auditor and N R Shah & Co as secretarial auditor for FY 2026-27. Both are routine appointments with no monetary value.
- Execution
- FY 2026-27
SC Agrotech Board Meeting Outcome
SC Agrotech's board approved shifting its corporate office to Sola, Ahmedabad, effective October 31, 2026. The registered office stays unchanged in Delhi.
Abril Paper Tech Board Meeting Outcome
Abril Paper Tech appointed K. J. Tapiawala & Associates as internal auditor for FY 2026-27. The appointment is a routine auditor change with no financial or operational impact.
- Execution
- Financial Year 2026-27
Bridge Securities Board Meeting Outcome
Bridge Securities' board approved moving its registered office within Ahmedabad, effective 31 October 2026. The routine administrative change has no financial impact.
VCU Data Management Board Meeting Outcome
VCU Data Management appointed M/s. Utkarsh Shah & Co. as Secretarial Auditors for five years from FY 2026-27, subject to AGM approval. No monetary amount is disclosed, so this is an auditor appointment intimation.
- Execution
- FY 2026-27 to 2030-31 (five years)